|
J. Biol. Chem., Vol. 265, Issue 11, 6155-6163, 04, 1990
Affinity labeling of rat liver and kidney type I 5'-deiodinase. Identification of the 27-kDa substrate binding subunit
J Kohrle, UB Rasmussen, DM Ekenbarger, S Alex, H Rokos, RD Hesch and JL Leonard
Department of Physiology, University of Massachusetts Medical School, Worcester 01655.
Extrathyroidal production of 3,3',5-triiodothyronine from the thyroid
secretory product, thyroxine, is catalyzed by tissue-specific iodothyronine
5'-deiodinases. Type I 5'-deiodinase (5'D-I) produces greater than 75% of
the T3 found in the circulation and in thyroid hormone-responsive tissues
and is most abundant in rat liver and kidney. In this study, we used the
bromoacetyl derivatives of T4 (N- bromoacetyl-[125I]L-thyroxine, BrAcT4)
and T3 (N-bromoacetyl- [125I]3,3',5-triiodothyronine, BrAcT3) as alkylating
affinity labels to identify 5'D-I-related protein(s). BrAcT4 and BrAcT3
rapidly and irreversibly inactivated 5'D-I activity in liver and kidney
microsomes. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of
affinity labeled 5'D-I preparations showed that approximately 80% of the
affinity label was incorporated into a protein with a Mr of 27,000 (p27).
5'D-I substrates and inhibitors specifically blocked affinity labeling of
p27 with a rank order of potency (BrAcT4 greater than BrAcT3 greater than
3,5,3'-triiodothyronine (rT3) approximately flavone EMD 21388 greater than
iodoacetate greater than N-acetyl-T4 (NAcT4) greater than N-acetyl-T3
(NAcT3] identical to that determined for inhibition of 5'-deiodination.
Hyper- and hypothyroidism-induced increases and decreases in 5'D-I
activity, respectively, were matched by comparable changes in the quantity
of affinity labeled p27. BrAcT3 was a less effective affinity label for p27
and minor labeling of a new band with 53 kDa was observed. Molecular sieve
chromatography of detergent-solubilized 5'D-I showed coincident peaks of
p27 and 5'- deiodinating activity with an apparent Mr approximately 51,000.
Two- dimensional gel electrophoresis showed that p27 was a single
polypeptide with a pI of 6.1. Approximately 2-5 pmol of p27 were present
per mg of liver microsomal protein, equal to previous estimates for 5'D-I
content. Our results suggest that p27 represents the substrate binding
subunit of type I 5'-deiodinase, the enzyme catalyzing the key reaction in
the activation of T4 to the thyromimetically active T3.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont
Selenium, the Thyroid, and the Endocrine System
Endocr. Rev.,
December 1, 2005;
26(7):
944 - 984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G J M Kuiper, W. Klootwijk, and T. J Visser
Expression of recombinant membrane-bound type I iodothyronine deiodinase in yeast
J. Mol. Endocrinol.,
June 1, 2005;
34(3):
865 - 878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Leonard, G. Simpson, and D. M. Leonard
Characterization of the Protein Dimerization Domain Responsible for Assembly of Functional Selenodeiodinases
J. Biol. Chem.,
March 25, 2005;
280(12):
11093 - 11100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Shepherdley, W. Klootwijk, K. W. Makabe, T. J. Visser, and G. G. J. M. Kuiper
An Ascidian Homolog of Vertebrate Iodothyronine Deiodinases
Endocrinology,
March 1, 2004;
145(3):
1255 - 1268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. J. M. Kuiper, F. Wassen, W. Klootwijk, H. van Toor, E. Kaptein, and T. J. Visser
Molecular Basis for the Substrate Selectivity of Cat Type I Iodothyronine Deiodinase
Endocrinology,
December 1, 2003;
144(12):
5411 - 5421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser
Substitution of Cysteine for Selenocysteine in the Catalytic Center of Type III Iodothyronine Deiodinase Reduces Catalytic Efficiency and Alters Substrate Preference
Endocrinology,
June 1, 2003;
144(6):
2505 - 2513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser
Substitution of Cysteine for a Conserved Alanine Residue in the Catalytic Center of Type II Iodothyronine Deiodinase Alters Interaction with Reducing Cofactor
Endocrinology,
April 1, 2002;
143(4):
1190 - 1198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen
Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases
Endocr. Rev.,
February 1, 2002;
23(1):
38 - 89.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Leonard, D. M. Leonard, M. Safran, R. Wu, M. L. Zapp, and A. P. Farwell
The Mammalian Homolog of the Frog Type II Selenodeiodinase Does Not Encode a Functional Enzyme in the Rat
Endocrinology,
May 1, 1999;
140(5):
2206 - 2215.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. C. Sun, J. W. Harney, M. J. Berry, and P. R. Larsen
The Role of the Active Site Cysteine in Catalysis by Type 1 Iodothyronine Deiodinase
Endocrinology,
December 1, 1997;
138(12):
5452 - 5458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Safran, A. P. Farwell, and J. L. Leonard
Catalytic Activity of Type II Iodothyronine 5'-Deiodinase Polypeptide Is Dependent upon a Cyclic AMP Activation Factor
J. Biol. Chem.,
July 5, 1996;
271(27):
16363 - 16368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Stachelek, T. F. Kowalik, A. P. Farwell, and J. L. Leonard
Myosin V Plays an Essential Role in the Thyroid Hormone-dependent Endocytosis of Type II Iodothyronine 5'-Deiodinase
J. Biol. Chem.,
October 6, 2000;
275(41):
31701 - 31707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Leonard, T. J. Visser, and D. M. Leonard
Characterization of the Subunit Structure of the Catalytically Active Type I Iodothyronine Deiodinase
J. Biol. Chem.,
January 19, 2001;
276(4):
2600 - 2607.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|